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Background: Emergency abdominal surgery carries a high risk of postoperative morbidity
and mortality. Goal directed therapy has been advocated to improve outcome in high-
risk surgery. The aim of the present pilot study was to examine the effect of goal directed
therapy using fluid alone on postoperative renal function and organ failure score in
patients undergoing emergency abdominal surgery.
Methods: This prospective randomised pilot study included patients over the age of 50
undergoing emergency abdominal surgery. In the intervention group pulse pressure varia-
tion measurements were used to guide fluid boluses of 6% Hydroxyethylstarch 130/0.4. The
control group received standard care. Serum urea, creatinine and cystatin C levels were
measured prior to and at the end of surgery and postoperatively on day 1, day 3 and day 5.
Results: Thirty patients were recruited. One patient died prior to surgery and was excluded
from the analysis. The intervention group received a median of 750 ml of hydroxyethyl-
starch. The peak values of postoperative urea were 6.9 (2.7–31.8) vs. 6.4 (3.5–11.5) mmol/l
( p¼ 0.425), creatinine 100 (60–300) vs. 85 (65–150) mmol/l ( p¼ 0.085) and cystatin C 1.09
(0.66–4.94) vs. 1.01 (0.33–2.29) mg/dl ( p¼ 0.352) in the control and intervention group,
respectively.
Conclusions: In the present pilot study replacing the identified fluid deficit was not associ-
ated with a change in renal function. These results do not preclude that goal directed ther-
apy using fluid alone may have an effect on renal function but they would suggest that the
effect size of fluid optimisation alone on renal function is small.
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status.2,3 Biondo and coworkers reported, that following
emergency abdominal surgery, multiple organ failure was
also important risk factor for 30-day mortality.4 It is of par-
ticular interest that renal failure, as indicated by a raised cre-
atinine5 or urea3 were associated with an increased 30-day
mortality.
Standard treatment for high-risk surgical patients is to
maintain cardiovascular parameters such as blood pressure,
heart rate, central venous pressure and urine output within
the normal range using fluids initially and inotropic agents if
required. ‘‘Goal directed therapy’’ aims to optimise the cardio-
vascular system and in particular oxygen delivery to support
vital organs including renal function.6–8 This treatment strat-
egy employs fluids in addition to inotropes to achieve this
cardiovascular goal. Although this approach has been associ-
ated with a reduced 30-day mortality it remained controver-
sial for a number of reasons. Firstly, it involved complex and
heterogeneous protocols which were difficult to transfer
from the research stage into clinical practice. Furthermore,
the protocols involved invasive monitoring and inotropes
and therefore required peri-operative admission to the inten-
sive care unit with significant resource implications. As a con-
sequence implementation of these strategies has not been
widespread. Moreover the respective values of fluid optimisa-
tion and the provision of inotropes are also not well under-
stood.9 In several studies, in patients undergoing elective
abdominal surgery, intraoperative optimisation with fluids
alone and without the use of inotropes, was associated with
improved outcomes such as reduced hospital stay and im-
proved gastrointestinal function.10–12 Clearly, if it was shown
that in emergency abdominal surgery goal directed therapy
using fluid alone during the intraoperative period had signifi-
cant value then this simplified low risk approach could then
be more readily incorporated into clinical practice.
The aim of the present pilot study was to examine the
effect of intraoperative goal directed therapy using fluid alone
on postoperative renal function and organ failure score in
patients undergoing emergency abdominal surgery.2. Patients and methods
2.1. Study setting and patients
Local research ethics committee approval and written in-
formed consent was obtained for this study. Patients, aged
50 years or over, who were to undergo emergency abdominal
surgery at the Royal Infirmary, Glasgow between September
2003 and February 2005 were included in the study. Patients
were recruited between the hours of 8 am and 8 pm on week-
days. Patients who presented in a state of emergency follow-
ing trauma, were to undergo vascular surgery, in whom
surgery was expected to last less than 90 min or who were
on lithium drug therapy were excluded from the study.
2.2. Study design and randomisation
Patients eligible for this randomised controlled study were
allocated to control and intervention arms using opaquesealed envelopes immediately prior to surgery. The study
group allocationwas not blinded as the control group received
no form of study intervention. Fluid optimisation was carried
out by three investigators (JH, BMcC, AH) none of whom were
present at the operations in the control group.
2.3. Intervention
In the intervention group an arterial line was sited and
connected to the Lidco cardiovascular monitor according to
manufacturer’s instructions (Lidco plus system, Lidco Ltd.,
Cambridge, UK). This monitor displays cardiac output, stroke
volume, heart rate, systemic vascular resistance, systemic
oxygen delivery and pulse pressure variations. Fluid boluses
of 250 ml of 6% hydroxyethylstarch 130/0.4 (Voluven, Frese-
nius Ltd., Cheshire, UK) were administered over 15 min during
the operation if the pulse pressure varied by more than 10%
(modified from Michard and colleagues13). This was in addi-
tion to the normal fluid administration by the anaesthetist
in charge of the patient. Data were recorded manually in
15-min intervals throughout the operation.
The clinical team in charge of the patient in the interven-
tion group did not have access to the data provided by the
Lidco monitor or the volume of hydroxyethylstarch adminis-
tered during the operation by the research team.
The control group received standard care by the clinical
team in charge of the patient without the investigator being
present in the theatre. The type of anaesthesia in both study
arms was at the discretion of the anaesthetist in charge of
the patient. At the end of the surgical procedure, the pulse
contour analysis monitor was disconnected. Postoperatively
both patients, in the protocol and intervention group, were
managed in the High Dependency or Intensive Care Unit and
discharged to the ward when clinically deemed appropriate.
2.4. Outcome measures
Urea, creatinine and cystatin C were measured to assess renal
function prior to surgery, immediately postoperatively, day 1,
day 3 and day 5 following surgery. Arterial and venous blood
gas samples were measured if an arterial or central venous
line was clinically indicated (following the induction of anaes-
thesia (n¼ 22), at the end of surgery (n¼ 25), day 1 (n¼ 20), day
3 (n¼ 7) and day 5 (n¼ 3)). The effects of serum electrolytes
and weak acids on base excess were calculated using the
simplified approach as described by Story et al.14
The Sequential Organ Failure Assessment (SOFA) scorewas
calculated to assess organ function prior to and following sur-
gery on day 1, day 3 and day 5 as described by Vincent and
coworkers.15 The score was modified in patients in whom ar-
terial blood gases were not available. In these patients the
PaO2/FiO2 ratio was substituted with the oxygen flow required
to obtain an oxygen saturation >94% as follows: score of 0 if
<2 l/min; score of if 2–3 l/min; score of 1 if 4–7 l/min; score of
3 if >7 l/min.
The Systemic Inflammatory Response Syndrome (SIRS)
score were assessed prior to and following surgery on day 1,
day 3 and day 5.16 The Revised Cardiac Risk Index17 and
POSSUM18 scores were documented immediately before
emergency surgery.
Table 1 – Pre-operative characteristics of control and
intervention groups in patients undergoing emergency
abdominal surgery (n[ 29)
Control
(n¼ 15)
Intervention
(n¼ 14)
p-
Value
Age (years) 64 (51–76) 66 (56–75) 0.377
Gender (female/male) 3/12 3/11 0.666
BMI 26 (18–38) 23 (17–37) 0.172
i n t e rn a t i o n a l j o u rn a l o f s u r g e r y 6 ( 2 0 0 8 ) 1 9 7 – 2 0 4 199The Postoperative Morbidity Survey is validated for
patients following elective surgery usually associated with
a short length of hospital.19 We modified this score for emer-
gency surgery, with a corresponding longer length of hospital
stay, by assessing the incidence and pattern of postoperative
complications on day 5, day 15 and day 30 rather than day 3,
day 5 and day 7.
Mortality at 30 days and length of hospital stay was
confirmed from Greater Glasgow Health Board.
POSSUM (physiological) 18 (13–40) 22 (13–44) 0.189
ASA 3 (1–4) 3 (1–4) 0.937
LEE 3 (2–4) 3 (2–4) 0.589
SOFA 1 (0–3) 1 (0–6) 0.399
SIRS 1 (0–4) 1.5 (0–4) 0.4672.5. Statistics
Data were presented as median (range). Where appropriate
comparisons of data were carried out using the chi-square
test and Mann–Whitney test. Statistical analysis was per-
formed using SPSS software (SPSS Inc., Chicago, Illinois, USA).3. Results
During the study period 153 patients underwent emergency
abdominal surgery; of these 19% of patients did not meet
inclusion criteria of the study. A further 41% presented for sur-
gery out of hours and 20% could not give informed consent.
Thirty (20%) patients were recruited into the study (Fig. 1).
One patient who was randomised to the intervention group
died prior to surgery and did not receive the intervention.
This patient was excluded from the analysis.TOTAL NUMBER OF
LAPAROTOMIES
N=153
ELIGIBLE LAPAROTOMIES
N=124
TOTAL NUMBER OF
LAPAROTOMIES
SUITABLE FOR CONSENT
N=60
TOTAL NUMBER OF
LAPAROTOMIES
RANDOMISED
N=30
ANALYSED
LAPAROTOMIES
N=29
Patient died prior to surgery (n=1)
Consent not possible due to incapacity (n=30)
Out of hours presentation (n=64)
Did not meet inclusion criteria (n=29)
Fig. 1 – Flow chart of patients presenting for emergency
abdominal surgery.The pre-operative characteristics of the control and inter-
vention groups are shown in Table 1. The majority of patients
were over the age of 60 years, male, and had POSSUM (physio-
logical), ASA and Lee scores associated with increased risk of
peri-operative mortality. Patient characteristics were similar
in control and intervention groups.
The intraoperative characteristics of the control and inter-
vention groups are shown in Table 2. The site, severity and du-
ration of surgery and anaesthetic technique were similar
between the groups. Also the administration of crystalloids,
colloids and fluid balance were similar in both groups. The in-
tervention group received a median of 750 ml hydroxyethyl-
starch. The median central venous pressure ( p< 0.01) and
the hourly urine output ( p< 0.05) during surgery were higher
in the intervention group.
At the end of surgery there were no differences in venous
blood gases between the control and intervention groups.
Both groups had a mild acidosis, normal central venous
oxygen saturations and normal lactate concentrations.
Overall, the surgical POSSUMscorewas greater in the inter-
vention group ( p< 0.05). This may have been due to a trend
towards increased blood loss ( p¼ 0.377) and peritoneal soiling
( p¼ 0.177) in the intervention group.
The intraoperative haemodynamic characteristics of the
intervention group are shown in Table 3. The data for 2
patients in the intervention were not collected. Pulse pressure
variation ( p< 0.01) was higher, and cardiac output ( p< 0.05)
and stroke volume ( p< 0.05) were lower following induction
of anaesthesia than at the end of surgery. The haemoglobin
concentration and oxygen content of blood were lower at
the end of surgery than following induction of anaesthesia
( p< 0.01). There was no significant difference in oxygen deliv-
ery between the start and end of surgery.
The peri-operative characteristics of the control and inter-
vention groups during the initial 24 h are shown in Table 4.
There were no significant differences in haemodynamic or
fluid balance data for the groups.
Organ and renal function data in the peri-operative period
are shown in Table 5. In both control and intervention groups
the SOFA score peaked on day 1. The peak urea, creatinine and
cystatin C occurred either pre-operatively or on day 1. There
were no significant differences between the control and inter-
vention groups in the peak values of urea ( p¼ 0.425), creati-
nine ( p¼ 0.085) and cystatin C ( p¼ 0.352).
Table 2 – Intraoperative characteristics of control and intervention groups in patients undergoing emergency abdominal
surgery (n[ 29)
Control (n¼ 15) Intervention (n¼ 14) p-Value
Type of surgery
Duodenal ulcer repair 1 1
Small bowel resection 3 2
Cholecystectomy 1 1
Large bowel resection 9 8
Others 1 2
Duration of surgery (min) 120 (45–240) 100 (40–295) 0.497
Epidural catheter (yes/no) 6/9 7/7 0.588
CVP (yes/no) 14/1 10/4 0.119
IBP (yes/no) 12/3 14/0 0.077
Crystalloids (ml) 2000 (0–4000) 1750 (1000–3500) 0.947
Intraoperative inotropic support 1 1 1.0
Colloids (ml) 1000 (0–3500) 1000 (0–3000) 0.627
Hydroxyethylstarch (ml) 0 750 (0–1750) <0.001
Fluid balance (ml) 1910 (280–4543) 1515 (650–3250) 0.481
Blood loss 250 (0–750) 400 (0–2000) 0.172
Haemoglobin
Postinduction 10.7 (6.8–16.0) 11.1 (6.9–14.0) 0.838
End of operation 10.7 (7.4–13.5) 8.6 (6.9–13.5) 0.095
CVP highest (mmHg) 9 (0–12) 13 (9–17) 0.002
BP mean lowest (mmHg) 59.9 (46.5–83.2) 61.8 (39.9–93.2) 0.949
HR highest (beats/min) 100 (80–120) 100 (70–120) 0.715
Urine output (ml/h) 69 (0–333) 109 (57–393) 0.014
Temperature lowest (C) 36.5 (35.7–37.8) 36.4 (34.8–37.9) 0.576
End of surgery VBGs
Hþ (nmol/l) 47.0 (41.0–65.0) 49.4 (39.0–55.0) 0.910
BE (mmol/l) 0.10 (8.0 to 7.0) 3.0 (7.0 to 2.0) 0.616
CV SpO2 (%) 74.0 (54.0–83.0) 74.6 (65.0–89.0) 0.793
Lactate (mmol/l) 1.4 (0.6–4.0) 1.2 (0.7–2.0) 0.319
POSSUM (surgical) 15 20 0.014
VBGs¼ venous blood gas sample; CVP¼ central venous pressure monitoring; IBP¼ invasive arterial pressure monitoring.
i n t e r n a t i o n a l j o u r n a l o f s u r g e r y 6 ( 2 0 0 8 ) 1 9 7 – 2 0 4200The serum concentrations of albumin, sodium and
chloride in the peri-operative period are shown in Table 6.
The highest serum sodium and chloride concentration values
were either in recovery or on day 1 in both groups. The trough
value for albumin occurred immediately postoperatively.
There were no differences in peak values of serum sodium
( p¼ 0.112) and chloride ( p¼ 0.847) and trough values of
albumin ( p¼ 0.425) and calculated base deficit ( p¼ 0.425).Table 3 – Haemodynamic characteristics in the
intervention group at postinduction and at the end of
surgery
Postinduction
(n¼ 12)
End of surgery
(n¼ 12)
p-
Value
Pulse pressure
variation (%)
14.0 (3.3–33.0) 6.6 (3.3–14.5) 0.005
Cardiac output
(l/min)
5.05 (3.2–12.6) 5.95 (3.2–12.6) 0.023
Stroke volume (ml) 72.0 (44.0–137.0) 82.0 (43.0–136.0) 0.030
Haemoglobin (g/dl) 11.1 (6.9–14.0) 8.6 (6.9–13.5) 0.007
Oxygen content
(ml/l)
147.6 (105.5–178.4) 119.3 (95.2–176.4) 0.007
Oxygen delivery
(ml/min/m2)
352.5 (251.0–925.0) 440 (197–918) 0.799The PMS scores and length of hospital stay data of the con-
trol and intervention groups are shown in Table 7. There were
no significant differences in the number of patients that
remained in hospital on day 5 and day 30. On day 15 more pa-
tients were in hospital ( p< 0.05). There was a trend towards
more complications on day 15 in the intervention group (Table
8). Therewas no difference in overall length of stay ( p¼ 0.252).
Also, hospital and 30-day mortality was similar in the control
and intervention groups.Table 4 – Immediate postoperative (24 h) haemodynamic
and fluid balance data of control and intervention groups
in patients undergoing emergency abdominal surgery
(n[ 29)
Control
(n¼ 15)
Intervention
(n¼ 14)
p-
Value
Crystalloids (ml) 3100 (2200–4000) 3687 (1500–7500) 0.235
Colloids (ml) 0 (0–2250) 0 (0–1500) 0.403
Fluid balance (ml) 2055 (500–6205) 2935 (610–9570) 0.105
CVP lowest (mmHg) 1 (3 to12) 2 (4 to 6) 0.979
BP mean
lowest (mmHg)
63.1 (49.9–89.9) 63.1 (50.2–91.2) 0.892
HR highest (beats/
min)
100 (70–126) 100 (70–125) 0.821
Urine output (ml/h) 20 (0–50) 20 (0–50) 0.339
Table 5 – Peri-operative organ function scores and renal function parameters of control and intervention groups in patients
undergoing emergency abdominal surgery (n[ 29)
SOFA SIRS Urea (mmol/l) Creatinine (mmol/l) Cystatin C (mg/dl)
Control (n¼ 15)
Pre-operative 1 (0–3) 1 (0–4) 5.6 (2.3–30.0) 100 (70–260) 1.19 (0.74–3.95)
Recovery 5.2 (2.1–28.1) 95 (60–280) 0.99 (0.59–3.73)
Day 1 3 (0–10) 2 (0–4) 6.7 (2.2–31.8) 95 (60–300) 0.91 (0.71–4.94)
Day 3 2 (0–10) 2 (0–4) 3.8 (1.6–24.0) 80 (55–300) 0.91 (0.61–4.41)
Day 5 1 (0–5) 1 (0–3) 4.4 (2.1–23.8) 75 (37–260) 0.96 (0.69–3.64)
Intervention (n¼ 14)
Pre-operative 1 (0–6) 1 (0–4) 6.4 (2.3–12.3) 85 (55–160) 0.87 (0.64–2.48)
Recovery 5.2 (2.8–9.8) 77 (60–140) 0.8 (0.47–2.10)
Day 1 3 (1–4) 2 (0–4) 5.7 (3.5–10.5) 85 (60–150) 1.01 (0.63–2.29)
Day 3 2 (0–4) 1 (0–4) 4.2 (1.3–10.3) 68 (50–110) 0.86 (0.39–1.72)
Day 5 1 (0–3) 1 (0–2) 3.1 (1.2–11.9) 75 (43–140) 0.85 (0.53–1.52)
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In this randomised controlled pilot study, in patients undergo-
ing emergency abdominal surgery, the effect of fluid optimisa-
tionaloneonrenalandorgan functionwasexamined.Basedon
increased pulse pressure variations of greater than 10% we
identified amedianfluid deficit of 750 ml. However, the correc-
tion of the fluid deficitwith hydroxyethylstarchwas not signif-
icantly associated with either parameters of improved renal
function or with reduced complications and hospital stay.
This is, to our knowledge, the first study to examine the effect
of fluid optimisation alone in patients undergoing emergency
abdominal surgeryandprovidebaseline information for future
fluid alone intervention studies in these patients.
It has long been recognised that organ hypoperfusion has
beenassociatedwithpoorer outcomeand this has been the ba-
sis forusinggoal directed therapyasameans tooptimiseorgan
perfusion and oxygen delivery. A number of workers6–9 have
shown that goal directed therapy using the combination of
fluid and inotropes during the peri-operative period reduced
complications, lengthofhospital stay andmortality in patients
undergoing high-risk surgery. This effect has mainly been
observed in patients undergoing high-risk surgery with mor-
tality rates in excess of 20%.20 We have previously shownTable 6 – Peri-operative albumin, electrolytes and calculated b
undergoing emergency abdominal surgery (n[ 29)
Albumin (g/l) Sodium (mmo
Control (n¼ 15)
Pre-operative 36 (19–47) 138 (130–142
Recovery 24 (11–40) 140 (134–145
Day 1 26 (13–48) 140 (132–146
Day 3 28 (15–34) 139 (133–146
Day 5 28 (17–35) 139 (134–150
Intervention (n¼ 14)
Pre-operative 37 (16–43) 137 (132–142
Recovery 20 (13–28) 140 (130–144
Day 1 21 (15–35) 140 (133–146
Day 3 26 (21–35) 139 (130–144
Day 5 27 (21–36) 138 (132–144
BDENaCl þ Albumin¼ calculated base deficit.14that, in almost 600 patients between 1998 and 2000, the
30-daymortality inpatientsundergoing emergencyabdominal
surgery was 26% and therefore represent a suitable target
group for goal directed therapy.3
In the present study the operative mortality, at 10%, was
lower than expected. The reasons for the difference inmortal-
ity rates between the two cohorts is not clear. However, this
may reflect the small sample size. Alternatively, that 30-day
mortality in these patients had decreased in the period
between the two studies. Indeed, when we examined the out-
come of all patients who underwent emergency surgery
during the study period (n¼ 153) 30-day mortality was 21%.
This confirms that a relevant high-risk cohort was studied
but raises the issue of why mortality in the experimental
group (n¼ 29) was only 10%. When we examined the study
patients in detail, it would appear that obtaining consent
was more problematical in the higher risk patients and that
there was a tendency for high-risk patients to present for sur-
gery out with the daytime recruitment hours.
In this study the primary endpoint was renal function. In
order to assess renal function in detail we measured serum
urea, creatinine and cystatin C pre-operatively and through-
out the postoperative period. Despite this detailed examina-
tion of renal function there were no differences between thease deficit of control and intervention groups in patients
l/l) Chloride (mmol/l) BDENaCl þ Albumin
) 102 (84–108) 0.5 (9.5 to 7.8)
) 107 (95–115) 0.8 (6.5 to 8.3)
) 104 (100–111) 1.8 (4 to 6.3)
) 102 (99–114) 2.0 (3.3 to 10.3)
) 105 (97–116) 1.8 (2.3 to 6.3)
) 100 (95–109) 1.0 (7.3 to 7.5)
) 104 (100–112) 0.5 (6.5 to 11.5)
) 106 (97–114) 0.1 (6.8 to 5.0)
) 102 (99–111) 2.3 (6.0 to 5.8)
) 101 (89–107) 2.5 (3.8 to 12.7)
Table 7 – Postoperative characteristics of control and
intervention groups in patients undergoing emergency
abdominal surgery (n[ 29)
Control Intervention p-Value
PMS day 5 3 (0–6) 3 (0–6) 0.982
In hospital (yes/no) 15/0 14/0 1.000
PMS day 15 0 (0–5) 1 (0–7) 0.328
In hospital (yes/no) 4/11 9/5 0.042
PMS day 30 0 (0–1) 0 (0–1) 1.000
In hospital (yes/no) 1/12 1/12 1.000
Hospital stay (days) 12 (7–55) 17.5 (7–41) 0.122
ITU (yes/no) 4/11 5/10 0.690
HDU (yes/no) 14/1 14/0 0.326
30-Day mortality (alive/dead) 13/2 13/1 0.584
PMS¼ postoperative morbidity score; ITU¼ intensive care unit;
HDU¼ high dependency unit.
i n t e r n a t i o n a l j o u r n a l o f s u r g e r y 6 ( 2 0 0 8 ) 1 9 7 – 2 0 4202control and intervention groups. Similarly, there was no ben-
eficial effect on organ, gastrointestinal or hospital stay. The
reasons for the lack of therapeutic effect of fluid therapy are
unclear. It may be that the therapeutic effect of fluid optimisa-
tion is relatively small and would not have been detected in
the present pilot study. Indeed, in recent randomised studies
of elective surgical patients, undergoing fluid optimisation
alone, the effect on hospital stay was only of the order of
10–15%.10–12 This raises the issue of whether fluid optimisa-
tion alone can produce substantial benefits in the surgical
patient. It is also of interest that the initial cardiac output
was 5 l/min suggesting that these, and presumably also the
patients in the control group, were well resuscitated prior to
surgery and hence the effect size of fluid optimisation would
be expected to be relatively small. Furthermore, there may
be other factors that contribute to the lack of effect observed
in this study. Previous studies have identified a therapeutic ef-
fect only when the oxygen delivery was raised to predefined
targets.6–9 It is of interest that in this study, although stroke
volume and cardiac output increased in response to the fluid
therapy, oxygen delivery, as a consequence of a decreased ox-
ygen content, did not increase significantly. This could have
accounted for the lack of effect seen in this study. Moreover,
hydroxyethylstarch (Voluven), the solution used in this
study to optimise the cardiovascular system contains a highTable 8 – Characteristics of postoperative morbidity score
(day 15) of control and intervention groups in patients
undergoing emergency abdominal surgery (n[ 29)
Control Intervention p-Value
Pulmonary (yes/no) 2/13 2/12 0.941
Infection (yes/no) 4/11 3/11 0.742
Renal (yes/no) 2/13 5/9 0.159
Gastrointestinal (yes/no) 1/14 4/10 0.119
Cardiovascular (yes/no) 1/14 1/13 0.960
Neuro (yes/no) 0/15 2/12 0.129
Wound (yes/no) 2/13 1/13 0.584
Haematology (yes/no) 0/15 1/13 0.292
Pain (yes/no) 2/13 1/13 0.584
Total number
of patients with
complications (yes/no)
4/11 7/7 0.196chloride contents which could result in a hyperchloraemic
metabolic acidosis as a consequence of a reduced strong ion
difference. Such a metabolic derangement has been associ-
ated with impaired organ and renal function.21 It would there-
fore be possible that the potential beneficial effect of fluid
optimisation was mitigated by an excessive chloride load.
However, therewas no evidence of a reduced strong ion differ-
ence measured in this study to support this explanation. In
summary, the results of this pilot study would suggest that
the effect of fluid optimisation alone on renal or organ func-
tion in well-resuscitated patients undergoing emergency ab-
dominal surgery is small. This would therefore indicate that
further trials of the effect of fluid optimisation alone would
not only require much larger cohorts of patients than have
been studied to date but should also include those high-risk
individuals who are presenting out of hours or who are unable
to give consent for emergency surgery.
Peri-operative fluid therapy is part of routine care. How-
ever, the optimal fluid strategy is unclear. It has long been
recognised that fluid overload appears to be associated with
increased complications and a prolonged hospital stay.22 It is
of interest that peri-operative restriction of fluids was associ-
ated with improved outcome in some studies23–25 but not
others.26 Taken together the results of studies examining fluid
balance in high-risk surgical patients would suggest that fluid
should only be given to those patients with proven fluid defi-
cit. However, the best method to demonstrate a fluid deficit in
surgical patients is unclear. A number of researchers10–12 have
examined the use of oesophageal Doppler guided fluid therapy
during the intraoperative period in patients undergoing high-
risk surgery. In these studies fluid alone was associated with
fewer complications, in particular gastrointestinal complica-
tions, and reduced length of hospital stay. However, when
using this monitor we found that artefacts, in particular
resulting from diathermy, which is extensively used in
abdominal surgery, limited the usefulness of this device.
More recently, pulse pressure variation in response to
mechanical ventilation has been advocated to assess fluid
volume status.13 This technique has a number of advantages;
it is simple to use, non-invasive and in addition this technol-
ogy is free from interference by diathermy. Our study is the
first to show that this method is a feasible approach to intra-
operatively assessing fluid balance. We chose a pulse pressure
variation of more than 10% as the trigger for the administra-
tion of a bolus. The optimal trigger is unknown. Previous
work has identified patients to be fluid responsive if pulse
pressure variation varied by more than 13%.13 In the present
study the volume of fluid administered was higher than de-
scribed in previous work (750 vs. <500 ml) using the oesopha-
geal Doppler monitor. It is of interest that in the intervention
group of the present study a larger proportion of patients was
in hospital on day 15 and there was a trend towards increased
postoperative complications in the intervention group. It is
therefore possible that a low threshold trigger could have led
to excessive fluid administration and therefore be related to
the trend towards prolonged hospitalisation. Further work is
required to identify the optimal trigger for intraoperative fluid
administration when using pulse pressure variation.
Limitations of the present study include the small number
of patients recruited in a single centre. Nevertheless this is to
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patients undergoing emergency abdominal surgery. The study
included patients undergoing a wide spectrum of clinical
problems which was managed by varying anaesthetic and
surgical staff. As a consequence of this it was unfeasible to
standardise clinical management which resulted in larger
variability of clinical care and this could have mitigated the
potential effect of the intervention. The present study, al-
though not fully blinded, was randomised and the collection
of the postoperative data was carried out by an investigator
(JEMC) who was unaware of the patient allocation. Further-
more, in order to minimise the potential bias in the interven-
tion group the additional haemodynamic data and volume of
hydroxyethylstarch administered was concealed from the
clinical team in charge of the patient. Clearly, in the control
group the absence of additional cardiovascular monitoring
reduced potential bias but also meant that no comparative
intraoperative haemodynamic data could be recorded.
In summary, the results of the present pilot study show
that fluid optimisation based on pulse pressure variation is
feasible and identified a fluid deficit in patients undergoing
emergency abdominal surgery. However, replacing such fluid
was not associated with an improvement in renal or organ
function. Although these results do not preclude that goal
directed therapy using fluid alonemay have an effect on renal
function following emergency abdominal surgery, theywould,
however, suggest that the effect size of this intervention on
renal function is small. Fluid optimisation was also associated
with a prolongation of hospital stay and a trend towards
increased complications that may be related to excessive
volume of fluid.Conflicts of interest
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